Literature DB >> 25753662

An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex.

Megha A Desai1, Heather D Webb2, Leander M Sinanan3, J Neel Scarsdale4, Ninad M Walavalkar3, Gordon D Ginder5, David C Williams6.   

Abstract

The MBD2-NuRD (Nucleosome Remodeling and Deacetylase) complex is an epigenetic reader of DNA methylation that regulates genes involved in normal development and neoplastic diseases. To delineate the architecture and functional interactions of the MBD2-NuRD complex, we previously solved the structures of MBD2 bound to methylated DNA and a coiled-coil interaction between MBD2 and p66α that recruits the CHD4 nucleosome remodeling protein to the complex. The work presented here identifies novel structural and functional features of a previously uncharacterized domain of MBD2 (MBD2IDR). Biophysical analyses show that the MBD2IDR is an intrinsically disordered region (IDR). However, despite this inherent disorder, MBD2IDR increases the overall binding affinity of MBD2 for methylated DNA. MBD2IDR also recruits the histone deacetylase core components (RbAp48, HDAC2 and MTA2) of NuRD through a critical contact region requiring two contiguous amino acid residues, Arg(286) and Leu(287). Mutating these residues abrogates interaction of MBD2 with the histone deacetylase core and impairs the ability of MBD2 to repress the methylated tumor suppressor gene PRSS8 in MDA-MB-435 breast cancer cells. These findings expand our knowledge of the multi-dimensional interactions of the MBD2-NuRD complex that govern its function.
© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25753662      PMCID: PMC4381075          DOI: 10.1093/nar/gkv168

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  70 in total

Review 1.  Flexible nets. The roles of intrinsic disorder in protein interaction networks.

Authors:  A Keith Dunker; Marc S Cortese; Pedro Romero; Lilia M Iakoucheva; Vladimir N Uversky
Journal:  FEBS J       Date:  2005-10       Impact factor: 5.542

2.  Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs.

Authors:  R R Meehan; J D Lewis; S McKay; E L Kleiner; A P Bird
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

3.  The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences.

Authors:  B Bjellqvist; G J Hughes; C Pasquali; N Paquet; F Ravier; J C Sanchez; S Frutiger; D Hochstrasser
Journal:  Electrophoresis       Date:  1993-10       Impact factor: 3.535

4.  MBD2 contributes to developmental silencing of the human ε-globin gene.

Authors:  Jeremy W Rupon; Shou Zhen Wang; Merlin Gnanapragasam; Stefanos Labropoulos; Gordon D Ginder
Journal:  Blood Cells Mol Dis       Date:  2011-02-04       Impact factor: 3.039

5.  Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.

Authors:  Omar Y Mian; Shou Zhen Wang; Sheng Zu Zhu; Merlin N Gnanapragasam; Laura Graham; Harry D Bear; Gordon D Ginder
Journal:  Mol Cancer Res       Date:  2011-06-21       Impact factor: 5.852

6.  Unique physical properties and interactions of the domains of methylated DNA binding protein 2.

Authors:  Rajarshi P Ghosh; Tatiana Nikitina; Rachel A Horowitz-Scherer; Lila M Gierasch; Vladimir N Uversky; Kristopher Hite; Jeffrey C Hansen; Christopher L Woodcock
Journal:  Biochemistry       Date:  2010-05-25       Impact factor: 3.162

7.  Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation.

Authors:  Li-Mei Chen; Karl X Chai
Journal:  Int J Cancer       Date:  2002-01-20       Impact factor: 7.396

8.  Deficiency of Mbd2 suppresses intestinal tumorigenesis.

Authors:  Owen J Sansom; Jennifer Berger; Stefan M Bishop; Brian Hendrich; Adrian Bird; Alan R Clarke
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

9.  Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc.

Authors:  Dalia I Hammoudeh; Ariele Viacava Follis; Edward V Prochownik; Steven J Metallo
Journal:  J Am Chem Soc       Date:  2009-06-03       Impact factor: 15.419

10.  An androgen receptor N-terminal domain antagonist for treating prostate cancer.

Authors:  Jae-Kyung Myung; Carmen A Banuelos; Javier Garcia Fernandez; Nasrin R Mawji; Jun Wang; Amy H Tien; Yu Chi Yang; Iran Tavakoli; Simon Haile; Kate Watt; Iain J McEwan; Stephen Plymate; Raymond J Andersen; Marianne D Sadar
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

View more
  26 in total

1.  CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.

Authors:  Hai Pan; Stephanie M Bilinovich; Parminder Kaur; Robert Riehn; Hong Wang; David C Williams
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

Review 2.  The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.

Authors:  Alea A Mills
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 3.  Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology.

Authors:  Yongsheng Li; Yunpeng Zhang; Xia Li; Song Yi; Juan Xu
Journal:  Trends Biochem Sci       Date:  2019-04-29       Impact factor: 13.807

4.  CHD4 Is a Peripheral Component of the Nucleosome Remodeling and Deacetylase Complex.

Authors:  Jason K K Low; Sarah R Webb; Ana P G Silva; Hinnerk Saathoff; Daniel P Ryan; Mario Torrado; Mattias Brofelth; Benjamin L Parker; Nicholas E Shepherd; Joel P Mackay
Journal:  J Biol Chem       Date:  2016-05-27       Impact factor: 5.157

5.  MiR-520b inhibits the development of glioma by directly targeting MBD2.

Authors:  Sitong Cui; Liang Liu; Teng Wan; Lei Jiang; Yan Shi; Liangsheng Luo
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

6.  Molecular architecture of nucleosome remodeling and deacetylase sub-complexes by integrative structure determination.

Authors:  Shreyas Arvindekar; Matthew J Jackman; Jason K K Low; Michael J Landsberg; Joel P Mackay; Shruthi Viswanath
Journal:  Protein Sci       Date:  2022-09       Impact factor: 6.993

7.  MBD2 and EZH2 regulate the expression of SFRP1 without affecting its methylation status in a colorectal cancer cell line.

Authors:  Jun Yu; Yang Xie; Yuting Liu; Feng Wang; Mengying Li; Jian Qi
Journal:  Exp Ther Med       Date:  2020-10-22       Impact factor: 2.447

Review 8.  The Methyl-CpG-Binding Domain 2 and 3 Proteins and Formation of the Nucleosome Remodeling and Deacetylase Complex.

Authors:  Gage Leighton; David C Williams
Journal:  J Mol Biol       Date:  2019-10-15       Impact factor: 5.469

Review 9.  Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation.

Authors:  Kathleen H Wood; Zhaolan Zhou
Journal:  Front Genet       Date:  2016-05-26       Impact factor: 4.599

10.  Refinement of the subunit interaction network within the nucleosome remodelling and deacetylase (NuRD) complex.

Authors:  Mario Torrado; Jason K K Low; Ana P G Silva; Jason W Schmidberger; Maryam Sana; Mehdi Sharifi Tabar; Musa E Isilak; Courtney S Winning; Cherry Kwong; Max J Bedward; Mary J Sperlazza; David C Williams; Nicholas E Shepherd; Joel P Mackay
Journal:  FEBS J       Date:  2017-11-13       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.